Join to View Full Profile
8081 Innovation Park DrLevel 5 - Great Falls ClinicFairfax, VA 22031
Phone+1 571-472-1180
Fax+1 571-472-1197
Dr. Cannon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Timothy Cannon is an oncology specialist based in Fairfax, VA. He completed his residency in Internal Medicine at George Washington University and his fellowship in Hematology and Medical Oncology at NYU Grossman School of Medicine, having graduated from Rutgers Robert Wood Johnson Medical School in 2005. He has expertise in myeloproliferative disease and has authored numerous publications on topics such as colorectal cancer treatment and proteomics in cancer therapy.
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011
George Washington UniversityResidency, Internal Medicine, 2005 - 2008
Rutgers Robert Wood Johnson Medical SchoolClass of 2005
Certifications & Licensure
VA State Medical License 2005 - 2026
NY State Medical License 2008 - 2012
DC State Medical License 2005 - 2008
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- CRE25-033: A MET Amplified Metastatic Esophageal Adenocarcinoma Demonstrates Response to the MET Inhibitor Capmatinib.Nina Neill, Timothy Cannon, Raymond Wadlow
Journal of the National Comprehensive Cancer Network. 2025-03-28 - Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer.Changsong Qi, Lin Shen, Thierry Andre, Hyun Cheol Chung, Timothy L Cannon
European Journal of Cancer. 2025-03-04 - Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.Daniel H Ahn, Maya Ridinger, Timothy L Cannon, Lawrence Mendelsohn, Jason S Starr
Journal of Clinical Oncology. 2025-03-01
Press Mentions
DC-Area Cancer Doctor Hopes FDA Action Will Save More Lives of People with Colon CancerJuly 31st, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
